{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:15:38Z","timestamp":1780910138397,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015872","name":"Universit\u00e9 de Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012958","name":"Morocco Ministry of Higher Education Scientific Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118298","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:15:03Z","timestamp":1762218903000},"page":"118298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Functionalized nitrogen- and chalcogen-containing heterocyclic compounds as aromatase inhibitors: Design, synthesis and biological evaluation"],"prefix":"10.1016","volume":"302","author":[{"given":"Chang Ha","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Le Borgne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marouan","family":"Rami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fossart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Melnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8620-9256","authenticated-orcid":false,"given":"Maxime","family":"Liberelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efd","family":"Yous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118298_bib1","series-title":"Bathsheba's Breast: Women, Cancer & History","first-page":"9","author":"Olson","year":"2002"},{"key":"10.1016\/j.ejmech.2025.118298_bib2","series-title":"A Concise History of Breast Cancer","first-page":"59","author":"Lacroix","year":"2011"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118298_bib3","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3747\/co.v18i1.623","article-title":"Immune therapy for breast cancer in 2010-hype or hope?","volume":"18","author":"Florescu","year":"2011","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ejmech.2025.118298_bib4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0960-9776(09)70002-5","article-title":"Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer","volume":"18","author":"Chlebowski","year":"2009","journal-title":"Breast"},{"key":"10.1016\/j.ejmech.2025.118298_bib5","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1016\/S0021-9258(20)79735-8","article-title":"Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione","volume":"249","author":"Thompson","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib6","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/S0021-9258(20)79736-X","article-title":"The involvement of human placental microsomal cytochrome P-450 in aromatization","volume":"249","author":"Thompson","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0022-4731(88)90129-X","article-title":"6-Methyleneandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor","volume":"30","author":"Giudici","year":"1988","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.ejmech.2025.118298_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1749-6632.1990.tb34309.x","article-title":"Novel irreversible aromatase inhibitors","volume":"595","author":"Di Salle","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118298_bib9a","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/pgmj.46.537.409","article-title":"Aminoglutethimide: a \u201cside effect\u201d turned to therapeutic advantage","volume":"46","author":"Hughss","year":"1970","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ejmech.2025.118298_bib9b","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/j.1875-9114.1981.tb03557.x","article-title":"Aminoglutethimide: review of pharmacology and clinical use","volume":"1","author":"Santen","year":"1981","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejmech.2025.118298_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","volume":"28","author":"Dowsett","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118298_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.mce.2013.08.001","article-title":"Breast cancer: current and future endocrine therapies","volume":"382","author":"Palmieri","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.118298_bib12","series-title":"Endometriosis: Science and Practice","article-title":"Medical therapies: aromatase inhibitors","author":"Bulun","year":"2012"},{"key":"10.1016\/j.ejmech.2025.118298_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1447-0756.2011.01698.x","article-title":"Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: brief report and review of the literature","volume":"38","author":"AlHilli","year":"2012","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ejmech.2025.118298_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mce.2011.02.018","article-title":"Suppression of estrogen actions in human lung cancer","volume":"340","author":"Miki","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4\u20135","key":"10.1016\/j.ejmech.2025.118298_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jsbmb.2009.10.004","article-title":"Impact of aromatase inhibitors on bone health in breast cancer patients","volume":"118","author":"Geisler","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118298_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12032-007-9019-x","article-title":"Aromatase inhibitors: past, present and future in breast cancer therapy","volume":"25","author":"Dutta","year":"2008","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ejmech.2025.118298_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/14756360500220574","article-title":"Three-dimensional model of cytochrome P450 human aromatase","volume":"20","author":"Log\u00e9","year":"2005","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib18","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/s-0030-1250169","article-title":"Natural product compounds with aromatase inhibitory activity: an update","volume":"76","author":"Balunas","year":"2010","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118298_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/17460441.2013.768983","article-title":"Computational methods for the design of potent aromatase inhibitors","volume":"8","author":"Favia","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118298_bib20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1080\/07391102.2014.912152","article-title":"Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer","volume":"33","author":"Awasthi","year":"2015","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2025.118298_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201900659","article-title":"Design, synthesis, and biological evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole derivatives as possible anti-breast cancer agents","volume":"17","author":"Ananth","year":"2020","journal-title":"Chem. Biodiversity"},{"issue":"18","key":"10.1016\/j.ejmech.2025.118298_bib22","doi-asserted-by":"crossref","first-page":"16152","DOI":"10.1021\/acsomega.2c01497","article-title":"Design, synthesis, and molecular modeling studies of a novel benzimidazole as an aromatase inhibitor","volume":"7","author":"\u00c7evik","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118298_bib23","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/molecules25071642","article-title":"Synthesis, docking studies and biological activity of new benzimidazole-triazolothiadiazine derivatives as aromatase inhibitors","volume":"25","author":"\u00c7evik","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118298_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/ph17010088","article-title":"Towards a new generation of hormone therapies: design, synthesis and biological evaluation of novel 1,2,3-triazoles as estrogen-positive breast cancer therapeutics and non-steroidal aromatase inhibitors","volume":"17","author":"Rashdan","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118298_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202400701","article-title":"Synthesis, in vitro and in silico studies of novel bis-triazolopyridopyrimidines from curcumin analogues as potential aromatase agents","author":"Gomha","year":"2024","journal-title":"Chem. Biodiversity"},{"key":"10.1016\/j.ejmech.2025.118298_bib26","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1021\/jo00085a052","article-title":"AlCl3-DMF reagent in the friedel-crafts reaction. Application to the acylation reaction of 2(3H)-benzothiazolone","volume":"59","author":"Yous","year":"1994","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature07614","article-title":"Structural basis for androgen specificity and oestrogen synthesis in human aromatase","volume":"457","author":"Ghosh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118298_bib28","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1021\/jm300930n","article-title":"Novel aromatase inhibitors by structure-guided design","volume":"55","author":"Ghosh","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib29","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1139\/cjc-2017-0419","article-title":"Integrating regression and classification-based QSARs with molecular docking analyses to explore the structure-antiaromatase activity relationships of letrozole-based analogs","volume":"95","author":"Adhikari","year":"2017","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0223-5234(89)90164-5","article-title":"Acyl-7-dihydro-2,3-benzoxazin-1,4-ones-3 et propri\u00e9t\u00e9s normolip\u00e9miantes","volume":"24","author":"Moussavi","year":"1989","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib31","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.1016\/j.tet.2006.07.006","article-title":"Synthesis of 6- and 7-acyl-4H-benzothiazin-3-ones","volume":"64","author":"Carato","year":"2006","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.118298_bib32","first-page":"33","article-title":"Synthesis and pharmacological activities of 7-acylamino-2,3-benzoxazinones","volume":"19","author":"Aichaoui","year":"1984","journal-title":"Eur. J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2025.118298_bib33","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/jm00044a011","article-title":"Benzoselenazolinone derivatives designed to be glutathione peroxidase mimetics feature inhibition of cyclooxygenase\/5-lipoxygenase pathways and anti-inflammatory activity","volume":"37","author":"Galet","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0960-894X(99)00668-X","article-title":"The discovery of potent cRaf1 kinase inhibitors","volume":"10","author":"Lackey","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118298_bib35","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/S0040-4020(01)82317-6","article-title":"Regioselectivity in the C-acylation of 2(3H)-benzoxazolones","volume":"47","author":"Aichaoui","year":"1991","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.118298_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ardp.200400937","article-title":"Synthesis, analgesic and antiinflammatory properties of certain 5-\/6-acyl-3-(4-substituted-1-piperazinyl-methyl)-2-benzoxazolinones derivatives","volume":"338","author":"K\u00f6ksal","year":"2005","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.118298_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/14756360410001667319","article-title":"Synthesis and evaluation of benzoxazolinonic imidazoles and derivatives as non-steroidal aromatase inhibitors","volume":"19","author":"Nativelle-Serpentini","year":"2004","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0022-4731(89)90147-7","article-title":"Evidence that corticosterone is not an obligatory intermediate in aldosterone biosynthesis in the rat adrenal","volume":"34","author":"H\u00e4usler","year":"1989","journal-title":"J. Steroid Biochem."},{"issue":"Issue W1","key":"10.1016\/j.ejmech.2025.118298_bib39","doi-asserted-by":"crossref","first-page":"W469","DOI":"10.1093\/nar\/gkae254","article-title":"Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction","volume":"52","author":"Myung","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118298_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chroma.2004.02.053","article-title":"Determination of ionization constants of N-imidazole derivatives, aromatase inhibitors, using capillary electrophoresis and influence of substituents on pKa shifts","volume":"1035","author":"Foulon","year":"2004","journal-title":"J. Chromatogr. A"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118298_bib41","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jssc.200401761","article-title":"Enantiomeric resolution of new aromatase inhibitors by liquid chromatography on cellulose chiral stationary phases","volume":"28","author":"Danel","year":"2005","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.ejmech.2025.118298_bib42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jhet.11","article-title":"New imidazole derivatives of 2(3H)-benzazolones as potential antifungal agents","volume":"46","author":"Petrov","year":"2009","journal-title":"J. Het. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib43","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/jm00158a007","article-title":"Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl)piperidine-2,6-diones","volume":"29","author":"Hartmann","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118298_bib44","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/endo-97-2-458","article-title":"Initiation of precocious sexual maturation in the immature rat treated with dehydroepiandrosterone","volume":"97","author":"Knudsen","year":"1975","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118298_bib45","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0960-0760(90)90460-3","article-title":"Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor","volume":"37","author":"Bhatnagar","year":"1990","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118298_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-4731(89)90367-1","article-title":"An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitors","volume":"33","author":"H\u00e4usler","year":"1989","journal-title":"J. Steroid Biochem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118298_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118298_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13321-021-00522-2","article-title":"Gnina 1.0: molecular docking with deep learning","volume":"13","author":"McNutt","year":"2021","journal-title":"J. Cheminformatics"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:56:35Z","timestamp":1780908995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"alternative-id":["S0223523425010633"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118298","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functionalized nitrogen- and chalcogen-containing heterocyclic compounds as aromatase inhibitors: Design, synthesis and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118298"}}